SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-091732
Filing Date
2024-10-29
Accepted
2024-10-29 16:15:30
Documents
14
Period of Report
2024-10-29
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0218911-8k_180life.htm   iXBRL 8-K 32403
  Complete submission text file 0001213900-24-091732.txt   252337

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20241029.xsd EX-101.SCH 3787
3 XBRL DEFINITION FILE atnf-20241029_def.xml EX-101.DEF 26629
4 XBRL LABEL FILE atnf-20241029_lab.xml EX-101.LAB 36680
5 XBRL PRESENTATION FILE atnf-20241029_pre.xml EX-101.PRE 25253
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0218911-8k_180life_htm.xml XML 5810
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 241405909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)